Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Meningeal Carcinomatosis × osimertinib × Clear all

Phase

Status

Unknown 2 Completed 2 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 16 Lung Neoplasms 6 Small Cell Lung Carcinoma 1 Resectable Non-small Cell Lung Cancer 1 Recurrence 1 Rare Tumour 1 Neoplastic Cells, Circulating 1 Neoplasm, Residual 1 NSCLC 1 Meningeal Carcinomatosis 1 Brain Neoplasms 1

Interventions

Pemetrexed 2 pembrolizumab 1 peginterferon alfa-2b 1 osimertinib 1 lorlatinib 1 aflutinib 1 Radiotherapy 1 Interferons 1 Drug Therapy 1 Cyclophosphamide 1 AZD3759 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07361705 2026-01-23

Zorifertinib With Osimertinib for NSCLC With Meningeal Progression

Alpha Biopharma (Jiangsu) Co., Ltd.

Phase 1 Not yet recruiting

Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡